Key result
SNPs rs1625579 and rs4680 show no association with P3b amplitude decrease or impaired P50 suppression.
Why the study?
A large proportion of the genetic architecture of psychotic disorders remains unresolved, and electroencephalographical intermediate phenotypes may help study genetic risk loci for schizophrenia.
Are specific single nucleotide polymorphisms (SNPs) associated with schizophrenia-related electroencephalographical intermediate phenotypes (EIPs)?
Meta-Analysis (n=34,971)
Are specific single nucleotide polymorphisms (SNPs) associated with schizophrenia-related electroencephalographical intermediate phenotypes (EIPs)?
Evidence for SNP associations with schizophrenia-related electroencephalographical intermediate phenotypes remains limited to individual studies, with meta-analyses failing to confirm significant associations for key SNPs.
Null meta-analytic results for rs1625579 and rs4680 caution against biomarker use; leaves open identification of genetic links to schizophrenia EEG phenotypes.
Although substantial research into genetics of psychotic disorders has been conducted, a large proportion of their genetic architecture has remained unresolved. Electroencephalographical intermediate phenotypes (EIP) have the potential to constitute a valuable tool when studying genetic risk loci for schizophrenia, in particular P3b amplitude, P50 suppression, mismatch negativity (MMN) and resting state power spectra of the electroencephalogram (EEG). Here, we systematically reviewed studies investigating the association of single nucleotide polymorphisms (SNPs) with these EIPs and meta-analysed them when appropriate. We retrieved 45 studies (N = 34,971 study participants). Four SNPs investigated in more than one study were genome-wide significant for an association with schizophrenia and three were genome-wide suggestive, based on a lookup in the influential 2014 GWAS (Ripke et al., 2014). However, in our meta-analyses, rs1625579 failed to reach a statistically significant association with p3b amplitude decrease and rs4680 risk allele carrier status was not associated with p3b amplitude decrease or with impaired p50 suppression. In conclusion, evidence for SNP associations with EIPs remains limited to individual studies. Careful selection of EIPs and SNPs, combined with consistent reporting of effect sizes, directions of effect and p-values would aid future meta-analyses.
No takes yet. Share an insight, caveat, or question.
Hederih et al. (2020) conducted a meta-analysis in Schizophrenia (n=34,971). Single nucleotide polymorphisms (SNPs) was evaluated on Association of SNPs (rs1625579 and rs4680) with p3b amplitude decrease and impaired p50 suppression. Single nucleotide polymorphisms rs1625579 and rs4680 were not significantly associated with p3b amplitude decrease or impaired p50 suppression in schizophrenia-related meta-analyses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: